JPL Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
JPL Wealth Management's BMY Position: Q2 2026 in Review
JPL Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 43% in Q2 2026, selling an estimated $48.3K and leaving 1,119 shares worth $64.5K. The position accounts for 0.01% of the portfolio, ranked #226.
JPL Wealth Management first reported a position in BMY in Q3 2025 and has held it in 3 quarters since. The position peaked at $119K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- JPL Wealth Management held 1,119 shares of Bristol-Myers Squibb worth $64.5K as of Q2 2026.
- JPL Wealth Management sold 842 Bristol-Myers Squibb shares in Q2 2026, an estimated $48.3K.
- Bristol-Myers Squibb made up 0.01% of JPL Wealth Management's portfolio in Q2 2026, its #226 holding.
- JPL Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 3 quarters since.
- JPL Wealth Management's Bristol-Myers Squibb position peaked at $119K in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.